Free Trial

Microbix Biosystems (MBX) News Today

Microbix Presents Novel HSV Test Control at EMMD
Microbix Presenting at Muskoka Capital Conference
MBX Biosciences Announces Pricing of Initial Public Offering
Microbix Biosystems Inc. stock logo
Microbix Biosystems Inc. (TSE:MBX) Insider Acquires C$204,122.06 in Stock
Microbix Biosystems Inc. (TSE:MBX - Get Free Report) insider Microbix Biosystems Inc. purchased 600,359 shares of the firm's stock in a transaction that occurred on Friday, August 30th. The shares were bought at an average price of C$0.34 per share, with a total value of C$204,122.06.
Microbix Reports Continued Strong Results for Q3 Fiscal 2024
MBX:CA Microbix Biosystems Inc.
Microbix Reports Strong Results for Q2 Fiscal 2024
Microbix Biosystems Inc MBX
Microbix Biosystems Inc. (MBX.TO)
Microbix Collaborator Introduces New Lab Accreditation Program
Microbix’s Clot-Buster Drug Project Advances
Microbix Biosystems Inc. stock logo
Microbix Biosystems Inc. (TSE:MBX) Director Sells C$39,250.00 in Stock
Microbix Biosystems Inc. (TSE:MBX - Get Free Report) Director Bo Hollas sold 100,000 shares of the stock in a transaction dated Wednesday, February 28th. The shares were sold at an average price of C$0.39, for a total transaction of C$39,250.00.
Stocks in play: Microbix Biosystems Inc.
Microbix Biosystems Inc. stock logo
Microbix Biosystems (TSE:MBX) Stock Price Passes Above 50 Day Moving Average of $0.39
Microbix Biosystems (TSE:MBX) Share Price Crosses Above Fifty Day Moving Average of $0.39
Microbix Biosystems Inc.
Microbix Announces Issuance of Stock Options
Microbix Biosystems Inc. stock logo
Cameron Lionel Groome Sells 119,500 Shares of Microbix Biosystems Inc. (TSE:MBX) Stock
Microbix Biosystems Inc. (TSE:MBX - Get Free Report) Director Cameron Lionel Groome sold 119,500 shares of the business's stock in a transaction dated Wednesday, February 21st. The shares were sold at an average price of C$0.39, for a total transaction of C$47,023.25.
Microbix Biosystems Inc. stock logo
Microbix Biosystems (TSE:MBX) Shares Pass Above 50-Day Moving Average of $0.39
Microbix Biosystems (TSE:MBX) Stock Passes Above 50 Day Moving Average of $0.39
Microbix Reports Record Results for Q1 Fiscal 2024
Microbix Schedules Release of Results for Q1 Fiscal 2024
Microbix Achieves Further QAPs Sales Record
Microbix Reports Results for Q4 & Full-Year Fiscal 2023
Microbix & Seegene USA Jointly Enhancing Lab Test Accuracy
Microbix Presenting at Florida Capital Event Conference
Get Microbix Biosystems News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter.

Watch this before it gets removed (Ad)

If you missed it, my emergency election broadcast is now available - but will be removed soon

Click here to watch it now.

MBX Media Mentions By Week

MBX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

MBX
News Sentiment

0.00

0.41

Average
Medical
News Sentiment

MBX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

MBX Articles
This Week

0

1

MBX Articles
Average Week

Get Microbix Biosystems News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (TSE:MBX) was last updated on 10/24/2024 by MarketBeat.com Staff
From Our Partners